Alan Howard

Also affiliated with Cancer Clinic

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death”.

Validated graft-specific biomarkers identify patients at risk for chronic graft-versus-host disease and death

Journal of Clinical Investigation(2023)10.1172/jci168575

N/A

0.515DataRank · unranked

21 citations

Denggang Fu, Alan Howard, Mingwei Fei, Jianqun Kou, Morgan R. Little +6 more

Pre-MEASURE: FLT3 -ITD and mutated NPM1 measurable residual disease before allogeneic transplant in adults with AML in first remission

medRxiv(2022)10.1101/2022.10.21.22281322

N/A

0.126DataRank · unranked

1 citations

Gege Gui, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee +16 more

Prognostic Biomarkers for Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome in Myeloablative Allogeneic Hematopoietic Cell Transplantation: Results from the Blood and Marrow Transplant Clinical Trials Network 1202 Study

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.11.024

N/A

0DataRank · unranked

9 citations

Bradford A. Young, John E. Levine, Ran Reshef, Ryotaro Nakamura, Christopher Strouse +8 more

Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.06.011

N/A

0DataRank · unranked

6 citations

Alan Howard, David Avigan, Manisha Bhutani, Adam D. Cohen, Luciano J. Costa +22 more

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Bone Marrow Transplantation(2023)10.1038/s41409-023-02168-0

N/A

0DataRank · unranked

9 citations

Kristopher Attwood, Xiaojun Liu, George L. Chen, Hans Minderman, Amin M. Alousi +16 more

Pre-MEASURE: Multicenter evaluation of the prognostic significance of measurable residual disease testing prior to allogeneic transplantation for adult patients with AML in first remission.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7006

N/A

0DataRank · unranked

11 citations

Laura W. Dillon, Gege Gui, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew +15 more

Impact of Conditioning Intensity and Genomics on Relapse After Allogeneic Transplantation for Patients With Myelodysplastic Syndrome

JCO Precision Oncology(2021)10.1200/po.20.00355

N/A

0DataRank · unranked

25 citations

Gege Gui, Brent R. Logan, Mingwei Fei, Jack Ghannam, Yuesheng Li +17 more